Table 4 Post-Hoc comparison by glucocorticoid (GC) treatment (n = 10 for each group)
| Â | End-CPB [Mediator] | Sieving coefficient | ||||
|---|---|---|---|---|---|---|
GC | No-GC | p-value | GC | No-GC | p-value | |
C3a (ng/ml) | 58.5 [52.8–65.9] | 60.1 [41.1–74.9] | 1.0 | 1056% [752%–1596%] | 985% [825%–1285%] | 0.53 |
C5a (pg/ml) | 241.6 [145.9–303.2] | 35.2 [3.3–85.6] | 0.005 | 18% [14%–34%] | 180% [47%–400%] | 0.03 |
TNF (pg/ml) | 7.4 [6.2–11.0] | 18.8 [11.1–32.9] | 0.03 | 26% [19%–39%] | 1% [0%–8%] | 0.003 |
TRAIL (pg/ml) | 127.2 [106.3–257.8] | 288.1 [224.5–456.9] | 0.09 | 7% [6%–8%] | 3% [2%–4%] | 0.01 |
IL-17A (pg/ml) | 3.6 [2.9–4.3] | 4.9 [4.9–6.1] | 0.005 | 83% [69%–117%] | 56% [42%–60%] | 0.005 |
CCL3 (pg/ml) | 26.4 [20.2–57.2] | 77.2 [31.6–346.6] | 0.1 | 55% [27%–72%] | 13% [1%–17%] | 0.005 |
CCL4 (ng/ml) | 0.5 [0.4–0.6] | 0.8 [0.5 –2.2] | 0.06 | 25% [17%–36%] | 12% [4%–21%] | 0.02 |